Anticipated Effects of Higher-valency Pneumococcal Conjugate Vaccines on Colonization and Acute Otitis Media
Supporting Files
-
10 01 2024 ; 10-01-
-
Available in CDC Stacks on 2024-10-01T00:00:00Z
File Language:
English
Details
-
Alternative Title:Pediatr Infect Dis J
-
Personal Author:
-
Description:Background: ; Bacterial etiologies of acute otitis media (AOM) have shifted from the introduction of pneumococcal conjugate vaccines (PCVs), antibiotic selection and competition among species. We characterized Streptococcus pneumoniae (Spn), Haemophilus influenzae (Hflu) and Moraxella catarrhalis (Mcat) in the nasopharynx during well-child healthy visits and at the onset of AOM, and in middle ear fluid (MEF) of children with AOM to assess anticipated effects of higher-valency PCVs (PCV15 and PCV20). ; Methods: ; From September 2021 to September 2023, we conducted a prospective longitudinal cohort study of PCV13 immunized children 6–36 months old. MEF was collected via tympanocentesis. Serotyping and antibiotic susceptibility testing were performed on Spn, Hflu and Mcat isolates. ; Results: ; We obtained 825 nasopharyngeal and 216 MEF samples from 301 children. The order of frequency of nasopharyngeal colonization was Mcat, Spn and Hflu; Hflu was the predominant otopathogen in MEF. Among Spn isolates, non-PCV15, non-PCV20 serotypes predominated in the nasopharynx and in MEF; the most frequent serotype was 35B. Among MEF samples, 30% of Spn isolates were amoxicillin nonsusceptible; 23% of Hflu isolates and 100% of Mcat isolates were β-lactamase-producing. ; Conclusion: ; The majority of Spn isolates among young children were non-PCV15, non-PCV20 serotypes, especially serotype 35B; therefore, the impact of higher-valency PCVs in reducing pneumococcal colonization or AOM is expected to be limited. Hflu continues to be the most frequent AOM pathogen. Antibiotic susceptibility data suggest a high dose of amoxicillin/clavulanate or alternative drugs that are effective against contemporary mix of otopathogens could be considered for optimal empiric selection to provide the best efficacy.
-
Subjects:
- Humans
- Pneumococcal Vaccines
- Otitis Media
- Infant
- Child, Preschool
- Nasopharynx
- Prospective Studies
- Streptococcus pneumoniae
- Longitudinal Studies
- Female
- Moraxella catarrhalis
- Male
- Haemophilus influenzae
- Anti-Bacterial Agents
- Vaccines, Conjugate
- Pneumococcal Infections
- Microbial Sensitivity Tests
- Acute Disease
-
Keywords:
-
Source:Pediatr Infect Dis J. 43(10):1004-1010
-
Pubmed ID:38838209
-
Pubmed Central ID:PMC11408086
-
Document Type:
-
Funding:
-
Volume:43
-
Issue:10
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:a689963891541a5fc8c19dd451774eeb5e5ecd8a933524d4300fff1a4d10ffd73d85407cd6b5319efc4fb9b51c163972d2284b5fcbc4b0d1a22044c8aed19cca
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access